If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
7.15    0.00 (0.00%)
Bid:
6.90
Ask:
7.40
Spread: 0.50 (7.246%)
Market Cap: £49.22m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Notification of Major Holdings

17 Jul 2018 07:00

RNS Number : 8086U
hVIVO plc
17 July 2018
Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Hvivo PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Woodford Investment Management Ltd

City and country of registered office (if applicable)

9400 Garsington Road, Oxford, OX4 2HN, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

13/07/2018

6. Date on which issuer notified (DD/MM/YYYY):

16/07/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

26.13%

26.13%

78,223,614

Position of previous notification (if

applicable)

25.35%

25.35%

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B6ZM0X53

20,439,993

26.13%

SUBTOTAL 8. A

20,439,993

26.13%

Β 

Β 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Woodford Investment Management Ltd

26.13

0.00

26.13

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Β 

Place of completion

9400 Garsington Road, Oxford, OX4 2HN, United Kingdom

Date of completion

13/07/2018

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
HOLEANXKFANPEFF
Date   Source Headline
9th Jun 20267:00 amRNSHolding(s) in Company
1st Jun 202612:00 pmRNS-RConsultancy contract with Decoy Therapeutics
29th May 20267:00 amRNSGrant of awards under Long Term Incentive Plan
20th May 20267:00 amRNSCapital Markets Day
13th May 20261:40 pmRNSResult of AGM
12th May 20269:45 amRNSHolding(s) in Company
7th May 20267:00 amRNS£6m Influenza HCT contract signed
24th Apr 20266:14 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSHCT contract signed with ILiAD Biotechnologies
17th Apr 20267:00 amRNSAnnual Report & Notice of AGM
15th Apr 20267:00 amRNSFinal Results 2025
14th Apr 20267:01 amRNS-RhVIVO launches unified brand identity
14th Apr 20267:00 amRNSInfluenza HCT contract signed with Traws Pharma
7th Apr 20267:00 amRNSNotice of Results
26th Mar 20265:19 pmRNSHolding(s) in Company
27th Feb 20263:31 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSIssue of Equity and Total Voting Rights
16th Feb 20263:05 pmRNSHolding(s) in Company
11th Feb 20263:11 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSTrading Update
27th Jan 20267:00 amRNSNotice of Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
15th Dec 20252:47 pmRNSCEO & CFO Share Purchase
27th Nov 20257:00 amRNS-RMSD to acquire Cidara
20th Nov 20257:00 amRNS>£5 million CRS contracts signed
11th Nov 20257:00 amRNS-RPositive data from novel human challenge models
6th Nov 20255:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNS-RPresentation at Jefferies Healthcare Conference
27th Oct 20253:01 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSInterim results
4th Sep 20257:00 amRNSNotice of Results
1st Sep 20257:00 amRNSAppointment of Non-Executive Chair
29th Jul 20257:00 amRNSProposed appointment of Chair
22nd Jul 20257:00 amRNSH1 Trading update
18th Jul 20257:00 amRNSDirectorate Change
9th Jul 20257:00 amRNSNotice of Trading Update
1st Jul 20254:04 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNS-RPositive results from client Phase 2b field study
5th Jun 20251:00 pmRNSResult of AGM
2nd Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTrading update
29th May 20257:00 amRNSAppointment of Independent Non-Executive Director
12th May 20257:00 amRNSAnnual Report, Notice of AGM & Directorate Change
10th Apr 20257:05 amRNSExercise of Options
10th Apr 20257:00 amRNSFinal results
26th Mar 20251:51 pmRNSAIM Rule 17 and Schedule 2(g) Update
21st Mar 20257:00 amRNSNotice of Results
7th Mar 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAcquisition of Cryostore for up to £3.2m
17th Feb 20257:00 amRNS£2m hMPV characterisation study contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.